HOME Press Releases Mice Model Market worth 1.59 Billion USD by 2021



Mice Model Market worth 1.59 Billion USD by 2021


The report "Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (CRISPR, Microinjection), Application (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2021", analyzes and studies the major market drivers, restraints/challenges, and opportunities.

                  Request Sample                 Request Sample

Browse 116 market data tables and 46 figures spread through 269 pages and in-depth TOC on “Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (CRISPR, Microinjection), Application (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2021”
http://www.marketsandmarkets.com/Market-Reports/mice-model-market-1308.html
Early buyers will receive 10% customization on reports.

This report studies the global mice model market for the forecast period of 2016 to 2021. This market is expected to reach USD 1.59 Billion by 2021 from USD 1.11 Billion in 2016, at a CAGR of 7.5%.

The global mice model market is segmented on the basis of type, technology, application, service, and region. The report also provides a market for mice care products, by type.

By type, the mice model market is categorized into inbred mice, genetically engineered mice, conditioned/surgically modified mice, hybrid/congenic mice, outbred mice, and spontaneous mutant mice. The inbred mice are estimated to account for the largest share of the market, by type. However, knockout mice models are expected to be the fastest-growing market segment owing to high investments in the development of new and innovative knockout models and the popularity of CRISPR as a major gene editing tool.

By technology, the market is segmented into CRISPR, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies. Other technologies include genetically modified sperm-mediated gene transfer, virus/vector mediated gene transfer, liposome-mediated DNA & electroporation of DNA, biolistics, and TALENs & ZFN. In 2016, CRISPR technology is expected to command the largest share of the market.

The market is further segmented by application, which includes oncology studies, immunology & inflammation studies, diabetes studies, cardiovascular studies, central nervous system studies, and other disease studies. Other disease studies include rare diseases, renal disorders, toxicology, and hematopoiesis. In 2016, the oncology segment is expected to command the largest share of the market.

The mice model market, by service, has been segmented into breeding, quarantine, rederivation, cryopreservation, genetic testing, model in-licensing, and other services. Other services include surgical, line rescue, and in vivo pharmacology services. In 2016, breeding services are expected to command the largest share of the market.

The market also covers the mice care products market, by type, which includes bedding, cages, feed, and other products (gnotobiotic equipment, water systems, and accessories like washing systems, logistics, water purification systems, and sound absorption panels). In 2016, cages command the largest share of the global mice care products market.

On the basis of region, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is poised to account for the largest share of the market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is expected to grow at the highest CAGR during the forecast period.

Ongoing innovations in mice models, the popularity of humanized mice models, continuous support in the form of investments and grants, and growing R&D activities of pharmaceutical industries are some of the factors that are expected to drive the growth of the market in the coming years.

Charles River Laboratories International, Inc. (U.S.), The Jackson Laboratory (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo (U.K.), Laboratory Corporation of America Holdings (U.S.), JANVIER LABS (France), Harbour BioMed (China), TRANS GENIC, Inc. (Japan), genOway (France), and Horizon Discovery Group plc (U.S.) are some of the key players in the market.

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports